Clinical Trial Update: A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis

View source ↗

Summary

A multi-center prospective observational biomarker study in EGFR-mutant non-small cell lung cancer patients with leptomeningeal metastasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis
• Non-small Cell Lung Cancer

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Non-small Cell Lung Cancer, Leptomeningeal Metastasis | Status: UNKNOWN